Navigation Links
Bayer's Third Annual Virtual Walk for Hemophilia Raises Funds, Brings Together the Hemophilia Community
Date:11/20/2013

WHIPPANY, N.J., Nov. 20, 2013 /PRNewswire/ -- Bayer HealthCare and the National Hemophilia Foundation (NHF) today announced the successful conclusion of the third annual Virtual Walk for Hemophilia, an engaging, online contest designed to raise awareness and funds for those living with bleeding disorders.

The Virtual Walk for Hemophilia (www.walkforhemophilia.com) employs a website where visitors can virtually "walk" online in support of people with hemophilia. Virtual walkers choose which NHF chapter they support, and create customized avatars to represent themselves in the virtual walk.

As part of this year's Walk, Bayer provided $30,000 in sponsorship funds to the national office of the NHF and an additional $33,500 in sponsorship funds to the five chapters with the greatest number of walkers, for a total of more than $60,000.

"Bayer's Virtual Walk is a fun, exciting way for us to engage with the community," said Karen Krzmarzick, Executive Director of the Hemophilia Association of the Capital Area. "We're grateful for the sponsorship funds Bayer provided to us, and know that they will help us do even more for our constituents in the coming year."

The chapters receiving sponsorship funds are:

First place: Hemophilia Association of the Capital Area, with 2729 walkers, received $15,000
Second place: Nevada Chapter, NHF, with 1133 walkers, received $10,000
Third place: Bleeding Disorders Alliance Illinois, with 1075 walkers, received $5,000
Fourth place: Great Lakes Hemophilia Foundation, with 385 walkers received $2,500
Fifth place: Colorado Chapter, NHF, with 351 walkers, received $1,000

Bayer introduced a new twist this year, designed to increase awareness virally, by providing an additional walker "credit" to chapters whose participants shared the event on Twitter or Facebook.   In addition, any chapter with more than 500 virtual walkers received $500, and any chapter with more than 1,000 walkers received $1,000 in sponsorship funds. 

About Hemophilia A
Hemophilia A, also known as factor VIII deficiency or classic hemophilia, is a largely inherited bleeding disorder in which one of the proteins needed to form blood clots in the body is missing or reduced. Hemophilia A is the most common type of hemophilia and is characterized by prolonged or spontaneous bleeding, especially into the, joints, muscles or internal organs.

About Bayer HealthCare Pharmaceuticals Inc.
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare provides products for Cardiopulmonary Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

BAYER®  and the Bayer Cross® are registered trademarks of Bayer.

Forward-Looking Statement
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Intended for U.S. Media Only

KN28000713


'/>"/>
SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results
2. Cardium Reports On Third Quarter 2013 Financial Results And Recent Business Developments
3. Pressure BioSciences, Inc. Discusses Record Third Quarter Revenue, Strong Fourth Quarter Guidance, Significant Progress on New Instrument Systems, and Expectation to Pay-Off All Outstanding Convertible Notes at the SeeThruEquity Financial Conference
4. CorMedix to Report Third Quarter Financial Results on November 19, 2013
5. International Isotopes Inc. Announces Third Quarter And Nine Months 2013 Financial Results
6. ULURU Inc. Reports Third Quarter 2013 Financial Results
7. China Pharma Holdings, Inc. Reports Third Quarter 2013 Financial Results
8. Nephros Reports Third Quarter 2013 Financial Results and Completes Bridge Financing
9. Vermillion Reports Third Quarter 2013 Results
10. ConvaTec Announces 2013 Third Quarter Earnings Call
11. SPO Global Reports Results for Third Quarter 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets has announced ... Patients Treated at Proton Therapy Centers & Forecast" report to their ... The South Korean ... current market size in 2016. The Untapped Proton Therapy Market for ... USD in 2016. Proton Therapy plays an important role ...
(Date:3/29/2017)... 29, 2017  The leader in accelerated orthodontics, OrthoAccel ... Sam Daher , Manal Ibrahim , Kenji ... will be the featured microlecture presenters at the AcceleDent ... of Orthodontists (AAO) Annual Session, April 21-25, 2017. Orthodontists ... beginning daily at 11:20 a.m. On the opening morning ...
(Date:3/29/2017)... 2017  Maxor National Pharmacy Services, LLC ("Maxor"), a ... named Leah Bailey as General Counsel.  Bailey will ... company. With more than 13 years of ... focused on health care, Bailey joins the Maxor team ... Bailey advised the PBM, Specialty, and Mail Order business ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES ... has announced that Mercy Medical Center will serve as the official title sponsor of ... On Sunday, June 25, 2017, thousands of women will walk or run the course ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... several educational opportunities for attending prescribers at the upcoming World Congress, in Hollywood ... “A4M has always been recognized as the visionary leader in the training of ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... in Carnegie, OK, from Dr. Jamie Cameron, with or without a referral. ... to traditional orthodontic treatment. Depending on each patient’s case, treatment with the FASTBRACES ...
(Date:3/29/2017)... ... 2017 , ... Altima Technologies, Inc., the maker of popular ... assets and audio-video devices has recently updated its Visio Stencils library with new ... download shapes and stencils from http://www.VisioStencils.com. , New devices were added ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):